Cellmune 500mg tablet

• Organ transplant
  

Patients experience side effects after using Cellmune 500mg tablet, some can resolve on their own and some need proper medication attention to treat. Visit the doctor soon if any of these symptoms persist:

• Diarrhea
• Constipation
• Loss of appetite
• Shortness of breath
• Weight loss
• Increased heartbeat
• Headache
• Blood pressure problem
• Anemia

• Higher risk of developing lymphoma and other cancers
• Nausea, abdominal pain
• Infections, fever, or sore throat
• Unusual bleeding or bruising
• Low blood cell count
• Severe allergic reactions

• Doctor prescribed Cellmune 500mg tablet on an empty stomach at least one hour or two hours after meal, at the fixed time everyday. Do not crush or chew the tablet, swallow it with whole glass of water. ]
• Take it exactly as determined by the healthcare professional to ensure safe and effective treatment. Taking it in the wrong way may cause serious side effects and reduce its effectiveness and lead to complications with transplanted organ.
• Always follow medical advice and report any unusual symptoms the doctor Immedietly.​​
  

• When an organ such as kidney, heart or liver- sometimes the body considers it foreign instead of recognizing it as its own. Because of this, the body starts attacking the new organ.
• Cellmune 500mg tablet prevents the body from reacting incorrectly, helping it accept the new organ so that the body works properly.
• This is an immunosuppressant medication, supports the body in accepting the transplanted organ, allowing it to function properly and reducing the risk of complications.​
  

• Allison, A. C., & Eugui, E. M. (2000). Mycophenolate mofetil and its mechanisms of action. Immunopharmacology, 47(2-3), 85-118. https://pubmed.ncbi.nlm.nih.gov/10878285/
• Lipsky, J. J. (1996). Mycophenolate mofetil. The Lancet, 348(9038), 1357-1359. https://pubmed.ncbi.nlm.nih.gov/8918281/
• Zwerner, J., & Fiorentino, D. (2007). Mycophenolate mofetil. Dermatologic therapy, 20(4), 229-238. https://pubmed.ncbi.nlm.nih.gov/17970888/
• Sievers, T. M., Rossi, S. J., Ghobrial, R. M., Arriola, E., Nishimura, P., Kawano, M., & Holt, C. D. (1997). Mycophenolate mofetil. Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy, 17(6), 1178-1197.
• Ransom, J. T. (1995). Mechanism of action of mycophenolate mofetil. Therapeutic drug monitoring, 17(6), 681-684.​